Application of a Biphasic Test for Characterization of In Vitro Drug Release of Immediate Release Formulations of Celecoxib and Its Relevance to In Vivo Absorption
- 12 August 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 7 (5), 1458-1465
- https://doi.org/10.1021/mp100114a
Abstract
A biphasic in vitro test method was used to examine release profiles of a poorly soluble model drug, celecoxib (CEB), from its immediate release formulations. Three formulations of CEB were investigated in this study, including a commercial Celebrex capsule, a solution formulation (containing cosolvent and surfactant) and a supersaturatable self-emulsifying drug delivery system (S-SEDDS). The biphasic test system consisted of an aqueous buffer and a water-immiscible organic solvent (e.g., octanol) with the use of both USP II and IV apparatuses. The aqueous phase provided a nonsink dissolution medium for CEB, while the octanol phase acted as a sink for CEB partitioning. For comparison, CEB concentration−time profiles of these formulations in the aqueous medium under either a sink condition or a nonsink condition were also explored. CEB release profiles of these formulations observed in the aqueous medium from either the sink condition test, the nonsink condition test, or the biphasic test have little relevance to the pharmacokinetic observations (e.g., AUC, Cmax) in human subjects. In contrast, a rank order correlation among the three CEB formulations is obtained between the in vitro AUC values of CEB from the octanol phase up to t = 2 h and the in vivo mean AUC (or Cmax) values. As the biphasic test permits a rapid removal of drug from the aqueous phase by partitioning into the organic phase, the amount of drug in the organic phase represents the amount of drug accumulated in systemic circulation in vivo. This hypothesis provides the scientific rationale for the rank order relationship among these CEB formulations between their CEB concentrations in the organic phase and the relative AUC or Cmax. In addition, the biphasic test method permits differentiation and discrimination of key attributes among the three different CEB formulations. This work demonstrates that the biphasic in vitro test method appears to be useful as a tool in evaluating performance of formulations of poorly water-soluble drugs and to provide potential for establishing an in vitro−in vivo relationship.Keywords
This publication has 21 references indexed in Scilit:
- Dissolution of poorly water-soluble drugs in biphasic media using USP 4 and fiber optic systemClinical Research and Regulatory Affairs, 2009
- Characterization of a novel polymorphic form of celecoxibJournal of Pharmaceutical Sciences, 2006
- Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugsExpert Opinion on Drug Delivery, 2005
- Design of a dissolution system for the evaluation of the release rate characteristics of artemether and dihydroartemisinin from tabletsInternational Journal of Pharmaceutics, 2004
- Bioavailability of different artemisinin tablet formulations in rabbit plasma—correlation with results obtained by an in vitro dissolution methodJournal of Pharmaceutical and Biomedical Analysis, 1997
- Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution testJournal of Controlled Release, 1997
- Ibuprofen tablets: dissolution and bioavailability studiesInternational Journal of Pharmaceutics, 1983
- Dissolution Rates under Sink ConditionsJournal of Pharmaceutical Sciences, 1971
- Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage formsJournal of Pharmaceutical Sciences, 1967
- Simultaneous determination of dissolution and partitioning rates in vitroJournal of Pharmaceutical Sciences, 1967